Stocks and InvestingStocks and Investing
Thu, October 24, 2019
Wed, October 23, 2019
Tue, October 22, 2019
Mon, October 21, 2019
Fri, October 18, 2019
Thu, October 17, 2019

Matt Miksic Maintained (ABT) at Buy with Increased Target to $98 on, Oct 17th, 2019


Published on 2024-10-26 17:00:58 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $95 to $98 on, Oct 17th, 2019.

Matt has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matt


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Monday, October 14th, 2019
  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $94 on, Thursday, July 18th, 2019
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $93 on, Tuesday, July 16th, 2019